Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | ACP3 | P15309 | 1/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.37 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19244855 | 0.89 | MEN1 (0.41) | OPRM1CYP2D6NFKB1CXCL8 | |
| SCHEMBL381471 | 0.87 | NISCH (0.56) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL381490 | 0.86 | CFD (0.40) | OPRM1ADRB2ADRB1CXCL8 | |
| SCHEMBL19244837 | 0.86 | NISCH (0.41) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL381817 | 0.83 | OPRM1 (0.39) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL382108 | 0.82 | ALDH1A1 (0.41) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL409383 | 0.82 | OPRM1 (0.39) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL19244810 | 0.81 | OPRM1 (0.48) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL19244867 | 0.80 | OPRM1 (0.42) | NISCHOPRM1ADRB2ADRB1CYP2D6 | |
| SCHEMBL382428 | 0.80 | ACP3 (0.43) | ACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408751-B1 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | BAYER IP GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| EP-2408751-A1 | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof | Bayer Pharma Aktiengesellschaft (DE) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010105770-A1 | SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-09-23 | — | — | WO | disclosed |